Revenue Growth in MS Division
MS division sales were up 14% year-on-year, excluding divestitures, driven by CMP slurries and advanced deposition materials.
Cost Synergies and R&D Investments
$10 million to $15 million in annualized cost savings expected from combining AMH and MC divisions, to be reinvested in R&D and operational capabilities.
Progress in Taiwan and Colorado Facilities
Progress in customer qualifications in Taiwan and completion of Phase 1 building in Colorado, with production ramp expected in the second half of 2025.
Debt Reduction Achievements
Paid down approximately $1.9 billion of total debt since the CMC acquisition.
Positive Outlook for Molybdenum Opportunities
Key POR wins for molybdenum deposition materials with expectations for implementation in upcoming 3D NAND node transitions.